Subject(s)
Neurosciences/history , Visual Pathways/growth & development , Animals , Eye/growth & development , History, 20th Century , History, 21st Century , Humans , Optic Chiasm/growth & development , Optic Chiasm/physiology , Optic Nerve/growth & development , Optic Nerve/physiology , Visual Pathways/physiologyABSTRACT
The transcription factors Satb2 (special AT-rich sequence binding protein 2) and Ctip2 (COUP-TF interacting protein 2) have been shown to be required for callosal and corticospinal axon growth respectively from subtypes of cerebral cortex projection neurons. In this study we investigated early stages of directed axon growth in the embryonic mouse cerebral cortex, and studied the possible correlation with the expression of Satb2 and Ctip2. Electroporation of an EYFP-expressing plasmid at embryonic day 13.5 to label developing projection neurons revealed that directed axon growth is first seen in radially migrating neurons in the intermediate zone (IZ), prior to migration into the cortical plate, as has been suggested previously. Onset of expression of SATB2 and CTIP2 was also observed in the IZ, correlating well with this stage of migration and initiation of axon growth. Immunohistochemical staining through embryonic and early postnatal development revealed a significant population of Satb2/Ctip2 co-expressing cells, while retrograde axon tracing from the corpus callosum at embryonic day 18.5 back-labelled many neurons with bi-directional axon processes. However, through retrograde tracing and simultaneous immunohistochemical staining we show that these bi-directional processes do not correlate with Satb2/Ctip2 co-expression. Our work shows that although expression of these transcription factors correlates well with the appearance of directed axon growth during cortical development, the transcriptional code underlying the bi-directional axonal projections of early neocortical neurons is not likely to be the result of Satb2/Ctip2 co-expression.
Subject(s)
Axons/physiology , Cerebral Cortex/growth & development , Cerebral Cortex/metabolism , DNA-Binding Proteins/metabolism , Matrix Attachment Region Binding Proteins/metabolism , Repressor Proteins/metabolism , Transcription Factors/metabolism , Tumor Suppressor Proteins/metabolism , Animals , Axons/metabolism , Cerebral Cortex/embryology , Corpus Callosum/cytology , Corpus Callosum/growth & development , Electroporation/methods , Immunohistochemistry , Mice , Mice, Inbred C57BLABSTRACT
The anatomical association between sensory nerves and blood vessels is well recognised in the adult, and interactions between the two are important during development. Here we have examined the relationship between developing blood vessels and sensory neuronal cell bodies, which is less well understood. We show in the chick that the nascent dorsal root ganglia (DRG) lie dorsal to the longitudinal anastomosis, adjacent to the developing neural tube at the level of the sulcus limitans. Furthermore, the blood vessel is present prior to the neurons suggesting that it may play a role in positioning the DRG. We use the zebrafish cloche mutation to analyse DRG formation in the absence of blood vessels and show that the DRG are positioned normally. Thus, despite their close anatomical relationship, the patterning of the blood vessel and DRG alongside the neural tube is separable rather than interdependent.
Subject(s)
Blood Vessels/embryology , Ganglia, Spinal/embryology , Neural Crest/embryology , Sensory Receptor Cells/cytology , Animals , Chick Embryo , ChickensABSTRACT
Central neurons lose the ability for axonal re-growth during development and typically do not regenerate their axons following axotomy once they become mature unless given a growth-permissive environment i.e. peripheral nerve graft. In the present study, the growth responsiveness of purified retinal ganglion cells (RGCs) at different ages to neurotrophic factors and Schwann cell (SC)-secreted factors were examined directly. The purity of adult RGCs was 97% as assessed by retrograde labelling with 4,6-diamidino-2-phenylindole. The stability of cultures were demonstrated by long-term survival (30 days) in medium contained brain-derived neurotrophic factor (BDNF), ciliary neurotrophic factor (CNTF) and forskolin (F) (BCF). RGCs from postnatal (P) (P0, P4, P8, P21) and adult (P90) rats showed decreasing levels of survival and neuritogenesis when grown in BCF. In contrast, the opposite was observed in SC-conditioned medium (CM)-treated P0-P8 RGCs which were increasingly responsive. SCCM induced maximal neurite outgrowth in P8 RGCs via the activation of extracellular regulated kinase 1/2 (Erk1/2). Inhibition of mitogen-activated protein kinase-Erk1/2 signaling using an Erk1/2-specific inhibitor (UO126) abolished SCCM-induced Erk1/2 phosphorylation and neuritogenesis completely. Although both SCCM and BCF failed to sustain the same levels of growth in P21 or P90 cultures as observed in P8 cultures, SCCM promoted higher survival and neuritogenesis than BCF-treated adult RGCs. This study is the first report of adult rat RGC purification and demonstrates that mature RGCs need multiple factors for survival and neurite outgrowth.
Subject(s)
Cell Separation/methods , Ciliary Neurotrophic Factor/pharmacology , Colforsin/pharmacology , Mitogen-Activated Protein Kinase 3/metabolism , Neurites/physiology , Retinal Ganglion Cells/physiology , Age Factors , Aging , Animals , Cell Growth Processes , Cells, Cultured , Culture Media, Conditioned , Rats , Retinal Ganglion Cells/cytology , Retinal Ganglion Cells/drug effects , Schwann Cells/metabolism , Signal TransductionABSTRACT
We have investigated the localization of Nogo, an inhibitory protein acting on regenerating axons in the adult central nervous system, in the embryonic mouse retinofugal pathway during the major period of axon growth into the optic chiasm. In the retina, Nogo protein was localized on the neuroepithelial cells at E12 and at later stages (E13-E17) on radial glial cells. Colocalization studies showed expression of Nogo on vimentin-positive glia in the retina and at the optic nerve head but not on most of the TuJ1- and islet-1-immunoreactive neurons. Only a few immature neurons in the ventricular and peripheral regions of the E13 retina were immunoreactive to Nogo. In the ventral diencephalon, Nogo was expressed on radial glia, most strongly on the dense radial glial midline raphe within the chiasm where uncrossed axons turn and in the initial segment of the optic tract. In vitro studies showed that the Nogo receptor (NgR) was expressed on the neurites and growth cones from both the ventral temporal and dorsal nasal quadrant of the retina. In the optic pathway, NgR staining was obvious in the vitreal regions of the retina and on axons in the optic stalk and the optic tract, but not in the chiasm. These expression patterns suggest an interaction of Nogo with its receptor in the mouse retinofugal pathway, which may be involved in guiding axons into the optic pathway and in governing the routing of axons in the optic chiasm.
Subject(s)
Embryo, Mammalian/metabolism , Myelin Proteins/metabolism , Optic Chiasm/metabolism , Receptors, Cell Surface/metabolism , Visual Pathways/metabolism , Animals , Axons/physiology , Cells, Cultured , Embryo, Mammalian/physiology , Female , GPI-Linked Proteins , Mice , Mice, Inbred C57BL , Myelin Proteins/biosynthesis , Myelin Proteins/physiology , Nogo Proteins , Nogo Receptor 1 , Optic Chiasm/physiology , Pregnancy , Receptors, Cell Surface/biosynthesis , Receptors, Cell Surface/physiology , Visual Pathways/physiologyABSTRACT
We have investigated the role of Nogo, a protein that inhibits regenerating axons in the adult central nervous system, on axon guidance in the developing optic chiasm of mouse embryos. Nogo protein is expressed by radial glia in the midline within the optic chiasm where uncrossed axons turn, and the Nogo receptor (NgR) is expressed on retinal neurites and growth cones. In vitro neurite outgrowth from both dorsonasal and ventrotemporal retina was inhibited by Nogo protein, and this inhibition was abolished by blocking NgR activity. In slice cultures of the optic pathway, blocking NgR with a peptide antagonist produced significant reduction in the uncrossed projection but had no effect on the crossing axons. This result was confirmed by treating cultures with an anti-Nogo functional blocking antibody. In vitro coculture assays of retina and optic chiasm showed that NgR was selectively reduced on neurites and growth cones from dorsonasal retina when they contacted chiasm cells, but not on those from ventrotemporal retina. These findings provide evidence that Nogo signaling is involved in directing the growth of axons in the mouse optic chiasm and that this process relies on a differential regulation of NgR on axons from the dorsonasal and ventrotemporal retina.
Subject(s)
Axons/physiology , Growth Inhibitors/physiology , Myelin Proteins/physiology , Optic Chiasm/growth & development , Visual Pathways/growth & development , Animals , Coculture Techniques , Female , Functional Laterality/physiology , Growth Inhibitors/genetics , Membrane Proteins/genetics , Membrane Proteins/physiology , Mice , Mice, Inbred C57BL , Myelin Proteins/genetics , Nogo Proteins , Optic Chiasm/cytology , Optic Chiasm/embryology , Organ Culture Techniques , Visual Pathways/cytology , Visual Pathways/embryologyABSTRACT
We have examined the trophic effects of conditioned media obtained from purified murine Müller glia cells on chick purified sympathetic or dorsal root ganglia (DRG) neurons and on Retinal Ganglion Cells (RGC) from postnatal mice. Purified murine Müller glia cultures stained positively for vimentin, GFAP or S-100, but were negative for neuronal markers. Murine Müller glial conditioned medium (MMG) was concentrated and at 1:1 dilution supported 100% survival of chick or rat sympathetic neurons after 48 h compared to <5% in controls. Partial purification of the MMG using centriprep concentrators showed that trophic activity is from molecules above 10 kDa. MMG stimulated AKT, ERK and pStat3 in sympathetic neurons. Sympathetic or DRG neuronal survival induced by MMG was blocked by anti-human NGF, but not by anti-human CNTF (sympathetic) or by anti-BDNF (DRGs) neutralizing antibodies. MMG also induced neurite outgrowth in P4 mice retinal explants and on isolated RGC. RGCs plated on top of Müller glia cells had a much better survival rate (>80%, 96 h) compared to laminin+poly-L-lysine substrates. In conclusion, we show that purified mice Müller glia cultures secrete NGF that support peripheral neuronal survival and other unidentified trophic molecules that induce RGC survival and neuritogenesis.
Subject(s)
Central Nervous System/cytology , Culture Media, Conditioned/pharmacology , Neurites/drug effects , Neuroglia/physiology , Neurons/drug effects , Peripheral Nerves/cytology , Animals , Antibodies, Blocking/pharmacology , Blotting, Western , Brain-Derived Neurotrophic Factor/antagonists & inhibitors , Cell Count , Cell Survival/drug effects , Central Nervous System/drug effects , Ciliary Neurotrophic Factor/antagonists & inhibitors , Colforsin/pharmacology , Culture Media, Conditioned/chemistry , Extracellular Signal-Regulated MAP Kinases/drug effects , Humans , Mice , Nerve Growth Factors/antagonists & inhibitors , Nerve Growth Factors/pharmacology , Neuroglia/metabolism , Oncogene Protein v-akt/drug effects , Peripheral Nerves/drug effects , Rats , STAT3 Transcription Factor/drug effects , Superior Cervical Ganglion/cytology , Superior Cervical Ganglion/drug effects , Sympathetic Nervous System/cytology , Sympathetic Nervous System/drug effectsABSTRACT
Using Nogo antibodies with defined binding specificity, Nogo-B, but not Nogo-A, was localized on radial glia in the floor plate of mouse embryos. The presence of Nogo-B was confirmed in Nogo-A knockout mice. In explant cultures of embryonic day (E) 11 and E12 spinal cord, blocking of NgR function with antagonist peptide NEP1-40 reduced the crossing of newly arrived commissural axons, resulting in an accumulation of growth cones in the floor plate. Analysis of growth cone morphology demonstrated an increase in size of growth cones in the floor plate after peptide treatment, which was not detected in axons growing toward the midline. In knockout embryos, midline crossing was not affected by absence of Nogo-A. In co-culture experiments using collagen gel, floor plate showed a strong inhibitory effect on the extension of post-commissural neurites from the spinal cord. This effect was abolished by NEP1-40, and was observed neither in pre-commissural neurites, nor in post-commissural neurites grown with floor plate derived from Nogo-A knockout embryo. Furthermore, western blot analysis of conditioned medium from floor plates showed a truncated form of Nogo with molecular weight of 37 kDa, which could mediate the diffusible effect to axon growth. We conclude that Nogo-B is expressed in the floor plate of mouse embryo, which probably mediates axon crossing in the spinal cord by repelling axons out of the midline when they start upregulate NgR. Nogo acts on axon growth not only through a contact-mediated mechanism, but also through a diffusible mechanism.
Subject(s)
Axons/physiology , Gene Expression Regulation, Developmental/genetics , Nogo Proteins/metabolism , Spinal Cord/anatomy & histology , Age Factors , Animals , Axon Guidance/genetics , Coculture Techniques , Contactin 2/metabolism , Culture Media, Conditioned/chemistry , Embryo, Mammalian , Embryoid Bodies/metabolism , Female , Growth Cones/metabolism , In Vitro Techniques , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Netrin-1/metabolism , Nogo Proteins/genetics , Nogo Receptors/metabolism , Organ Culture Techniques , Pregnancy , Spinal Cord/embryology , Tubulin/metabolismABSTRACT
Expression of Nogo protein was investigated in the optic pathway of embryonic mice by using isoform-specific antibodies Bianca and 11C7, which recognize Nogo-A/B and Nogo-A, respectively. Our previous reports from using antibody N18 have shown that Nogo is localized on the radial glia in the retina and at the midline of the ventral diencephalon in mouse embryos during the ingrowth of retinal ganglion cells (RGCs) axons. This glial-specific localization is markedly different from findings in other studies. This study showed Nogo-A/B primarily on radial glia in the retina at E13 and then later on retinal ganglion cells and axons at E14 and E15, whereas Nogo-A was expressed preferentially by RGCs and their axons. In the ventral diencephalon, Nogo-A/B was expressed strongly on radial glia, particularly in those located in the midline region of the chiasm but also on RGC axons. In Nogo-A knockout embryos, the isoform Nogo-B (revealed by Bianca) was observed on radial glia in the ventral diencephalon and on RGCs and their axons. We concluded that Nogo-A is localized on the ganglion cells and retinal axons, whereas Nogo-B is expressed by the radial glia in the optic pathway. Nogo-B may play an important role in guiding axon growth in decisive regions of the visual pathway, which include the optic disc and the optic chiasm. J. Comp. Neurol. 524:2322-2334, 2016. © 2016 Wiley Periodicals, Inc.
Subject(s)
Nogo Proteins/biosynthesis , Visual Pathways/metabolism , Animals , Blotting, Western , Embryo, Mammalian , Immunohistochemistry , Mice , Mice, Inbred C57BL , Protein Isoforms/biosynthesisABSTRACT
Retinal axons undergo several changes in organization as they pass through the region of the optic chiasm and optic tract. We used immunocytochemistry to examine the possible involvement of fibroblast growth factor receptors (FGFR) in these changes in retinal axon growth. In the retina, at all ages examined, prominent staining for FGFR was seen in the optic fiber layer and at the optic disk. At embryonic day 15 (E15), FGFR immunoreactivity was also detected in the ganglion cell layer, as defined by immunoreactivity for islet-1. At later developmental stages (E16 to postnatal day 0), FGFR were found in the optic fiber layer and the inner plexiform layer. In the ventral diencephalon, immunostaining for FGFR was first detected at E13 in a group of cells posterior to the chiasm. These cells appeared to match the neurons that are immunopositive for the stage-specific embryonic antigen-1 (SSEA-1). FGFR staining was also found on the retinal axons at E13. At E14-E16, when most axons are growing across the chiasm and the tract, a dynamic pattern of FGFR immunoreactivity was observed on the retinal axons. The staining was reduced when axons reached the midline but was increased when axons reached the threshold of the optic tract. These results suggest that axon growth and fiber patterning in distinct regions of the retinofugal pathway are in part controlled by a regulated expression of FGFR. Furthermore, the axons with elevated FGFR expression in the optic tract have a posterior border of rich FGFR expression in the lateral part of the diencephalon. This region overlaps with a lateral extension of the SSEA-1-positive cells, suggesting a possible relation of these cells to the elevated expression of FGFR.
Subject(s)
Mice, Inbred C57BL/metabolism , Receptors, Fibroblast Growth Factor/biosynthesis , Retina/growth & development , Retina/metabolism , Visual Pathways/growth & development , Visual Pathways/metabolism , Animals , Axons/chemistry , Axons/metabolism , Female , Immunohistochemistry , Mice , Optic Chiasm/cytology , Optic Chiasm/growth & development , Optic Chiasm/metabolism , Pregnancy , Receptors, Fibroblast Growth Factor/analysis , Retina/cytology , Visual Pathways/cytologyABSTRACT
We have examined expression of L1 and the polysialic acid-associated form of the neural cell adhesion molecule (PSA-NCAM) in mouse embryos during the major period of axon growth in the retinofugal pathway to determine whether they are expressed in patterns that relate to the changes in axon organization in the pathway. Immunostaining for L1 and PSA-NCAM was found on all axons in the retina and the optic stalk. In the chiasm, while L1 immunoreactivity remained high on the axons, PSA-NCAM staining was obviously reduced. At the threshold of the optic tract, L1 immunoreactivity was maintained only in a subpopulation of axons, whereas PSA-NCAM staining was dramatically elevated in axons at the caudal part of the tract. Further investigations of the tract showed that both L1 and PSA-NCAM were preferentially expressed on the dorsal but not ventral optic axons, indicating a regionally specific change of both adhesion molecules on the axons at the chiasm-tract junction. Moreover, intense PSA-NCAM expression was also observed in the tract of postoptic commissure (TPOC), which lies immediately caudal to the optic tract. Immunohistochemical and retrograde tracing studies showed that these PSA-NCAM-positive axons arose from a population of cells rostral to the CD44-positive chiasmatic neurons. These findings indicate that, in addition to the chiasmatic neurons, these PSA-NCAM-positive diencephalic cells also contribute axons to the TPOC. These early generated commissural axons together with the regionally specific pattern of cell adhesion molecule expression on the optic axons may control formation of the partial retinotopic axon order in the optic tract through homophilic or heterophilic interactions that involve PSA-NCAM.
Subject(s)
Gene Expression Regulation, Developmental/physiology , Neural Cell Adhesion Molecule L1/biosynthesis , Retina/metabolism , Sialic Acids/biosynthesis , Visual Pathways/metabolism , Animals , Embryo, Mammalian , Female , Mice , Mice, Inbred C57BL , Neural Cell Adhesion Molecule L1/analysis , Neural Pathways/chemistry , Neural Pathways/embryology , Neural Pathways/metabolism , Optic Chiasm/chemistry , Optic Chiasm/embryology , Optic Chiasm/metabolism , Pregnancy , Retina/chemistry , Retina/embryology , Sialic Acids/analysis , Visual Pathways/chemistry , Visual Pathways/embryologyABSTRACT
The extensive period of retinal ganglion cell (RGC) neurogenesis in the rat is associated with a protracted sequence of arrival of their axons into central targets such as the superior colliculus (SC) (Dallimore et al., 2002). Using in utero 5-bromo-2'-deoxyrudine (BrdU) injections to label early (embryonic day (E) 15) or late (E18 or E19) born RGCs, we now show that E15 RGCs with axons that enter the SC prenatally undergo programmed cell death earlier than late-born RGCs whose axons only reach the SC late in the first postnatal week. These late-born RGCs do not begin to die until postnatal day (P) 5/6. Removal of retrograde trophic support by P1 SC ablation initially only affects E15 RGCs; however by P5 death of late-born RGCs is increased, confirming that a switch to target dependency is delayed in this cohort. In a further experiment it was found that, following complete rostral SC transection at P2, the proportion of post-lesion axons originating from E19 RGCs was significantly greater than the proportion that normally makes up the retinotectal projection. Thus, even in neonatal brain, uninjured late-arriving axons are more likely to grow across a lesion site than injured axons undergoing regeneration. To study if birth date also affects regenerative potential in adulthood, autologous peripheral nerve (PN) was grafted onto the cut optic nerve in mature BrdU labelled rats. We found that, compared to E15 RGCs, a significantly greater proportion of late-born RGCs survived axotomy, but comparatively fewer of these surviving E19 RGCs regrew an axon into a graft. In summary, this research shows that the birthdate of RGCs significantly impacts on their subsequent life history and response to injury. Understanding how developing central nervous system (CNS) neurons acquire dependency on target-derived trophic support may lead to new strategies for enhancing survival and regeneration in adult CNS.
Subject(s)
Apoptosis/physiology , Axons/physiology , Nerve Regeneration/physiology , Neurogenesis/physiology , Retinal Ganglion Cells/physiology , Acetylcholinesterase/metabolism , Animals , Brain/metabolism , Cell Count , Immunohistochemistry , In Situ Nick-End Labeling , Rats , Rats, Wistar , Retinal Ganglion Cells/cytology , Superior Colliculi/physiologyABSTRACT
Schwann cells (SCs) play a major role in the successful regeneration of peripheral nerves regeneration. Here we examined the effects of osteonectin (ON), a major factor secreted by SCs, on survival and neuritogenesis of mouse superior cervical ganglion (SCG) neurons. SC conditioned medium (SCCM) not only promoted the survival and neuritogenesis of SCG neurons at a level comparable to nerve growth factor (NGF) but also doubled the neurite length of NGF-treated SCG neurons. SCCM neuritogenic effects were not blocked by the tyrosine kinase receptor (Trk) inhibitor K252a demonstrating that these are not due solely to classical neurotrophic factors. Anti-ON neutralizing antibody diminished the SCCM-induced survival and neuritogenesis significantly. In the presence of K252a, the SCCM neuritogenic effects were blocked completely by anti-ON which suggests synergistic effects of ON with Trk-mediated growth factors. ON alone increased the survival and neurite outgrowth of SCG neurons significantly at high density cultures. ON at low concentration acts synergistically with NGF which induced maximum survival and neurite outgrowth (>50% increase). However, ON at high concentration was detrimental to survival (64% decrease) and neurite outgrowth (87% decrease) even in the presence of NGF. The well documented counter-adhesive effect of ON may account for this observation. Nevertheless, the growth promoting effects of ON became more pronounced as the cell density increased which suggests a possible interaction of ON with growth factors secreted by SCG neurons (autocrine or paracrine effects). Taken together, our study indicates that ON plays important roles in nervous system repair through its synergistic effects with growth factors.
Subject(s)
Nerve Growth Factor/pharmacology , Osteonectin/metabolism , Schwann Cells/metabolism , Superior Cervical Ganglion/growth & development , Analysis of Variance , Animals , Cell Count , Cell Survival/drug effects , Cells, Cultured , Culture Media, Conditioned , Drug Synergism , Immunohistochemistry , Mice , Neurites/drug effects , Neurites/physiology , Rats , Schwann Cells/cytology , Superior Cervical Ganglion/cytology , Superior Cervical Ganglion/drug effectsSubject(s)
Headache/etiology , Headache/physiopathology , Light/adverse effects , Retinal Ganglion Cells/physiology , Thalamus/physiopathology , Visual Pathways/physiopathology , Action Potentials , Animals , Blindness/physiopathology , Dura Mater/physiology , Humans , Models, Neurological , Neurons/cytology , Neurons/physiology , Photic Stimulation , Rats , Retinal Ganglion Cells/cytology , Thalamus/anatomy & histology , Thalamus/cytology , Visual Pathways/anatomy & histology , Visual Pathways/cytologyABSTRACT
We have investigated the factors made by Schwann cells (SCs) that stimulate survival and neurite outgrowth from postnatal rat retinal ganglion cells (RGCs). These effects are preserved under K252a blockade of the Trk family of neurotrophin receptors and are not fully mimicked by the action of a number of known trophic factors. To identify novel factors responsible for this regenerative activity, we have used a radiolabelling assay. Proteins made by SCs were labelled radioactively and then fed to purified RGCs. The proteins taken up by the RGCs were then isolated and further characterized. Using this assay we have identified a major 40 kDa factor taken up by RGCs, which was microsequenced and shown to be the matricellular protein osteonectin (ON). Using an in vitro assay of purified RGCs we show that ON promotes both survival and neurite outgrowth. We conclude that ON has a potential new role in promoting CNS repair.
Subject(s)
Cell Survival/physiology , Neurites/physiology , Osteonectin/pharmacology , Retinal Ganglion Cells/cytology , Schwann Cells/physiology , Animals , Animals, Newborn , Neurites/drug effects , Neurites/ultrastructure , Rats , Retinal Ganglion Cells/drug effects , Sciatic Nerve/physiologyABSTRACT
The adult mammalian central nervous system (CNS) does not repair after injury. However, we and others have shown in earlier work that the neonatal CNS is capable of repair and importantly of allowing regenerating axons to re-navigate through the same pathways as they did during development. This phase of neonatal repair is restricted by the fragility of neurons after injury and a lack of trophic factors that enable their survival. Our aim is to define better the factors that sustain neurons after injury and allow regeneration to occur. We describe some of our work using Schwann cells to promote the regeneration of neurons from young postnatal rodents. We have established rapid methods for purifying Schwann cells without the use of either anti-mitotic agents to suppress contaminating fibroblasts or mitotic stimulation to generate large numbers of Schwann cells. The rapidly purified Schwann cells have been used to generate conditioned medium that we have shown stimulates axon regeneration in cultured retinal ganglion cell neurons. We also show that the positive effects of Schwann cells are still present after pharmacological blockade of the neurotrophin receptors, suggesting that novel factors mediate these effects.
Subject(s)
Animals, Newborn/physiology , Mammals/physiology , Nerve Regeneration/physiology , Retinal Ganglion Cells/physiology , Schwann Cells/metabolism , Animals , Axonal Transport/physiologyABSTRACT
Retinal axons undergo an age-related reorganization at the junction of the chiasm and the optic tract. We have investigated the effects of removal of chondroitin sulphate on this order change in mouse embryos aged embryonic day 14, when most axons are growing in the optic tract. Enzymatic removal of chondroitin sulphate but not keratan sulphate in brain slice preparations of the retinofugal pathway abolished the accumulation of phalloidin-positive growth cones in the subpial region of the optic tract. The loss of chronotopicity was further demonstrated by anterograde filling of single retinal axons, which showed a dispersion of growth cones from subpial to the whole depth of the tract. The enzyme treatment neither produced detectable changes in growth cone morphology and growth dynamic of retinal neurites nor affected the radial glial processes in the tract, indicating a specific effect of removal of chondroitin sulphate from the pathway to the axon order in the tract. Although chondroitin sulphate was also found at the midline of the chiasm, growth cone distribution across the depth of fibre layer at the midline was not affected by the enzyme treatment. These results suggest a mechanism in which retinal axons undergo changes in response to chondroitin sulphate at the chiasm-tract junction, but not at the midline, that produce a chronotopic fibre rearrangement in the mouse retinofugal pathway.
Subject(s)
Aging/metabolism , Axons/enzymology , Chondroitin Sulfates/metabolism , Visual Pathways/embryology , Visual Pathways/enzymology , Aging/drug effects , Animals , Axons/drug effects , Chondroitin ABC Lyase/pharmacology , Embryo, Mammalian/drug effects , Embryo, Mammalian/enzymology , Female , Mice , Mice, Inbred C57BL , Neural Pathways/drug effects , Neural Pathways/embryology , Neural Pathways/enzymology , Pregnancy , Visual Pathways/drug effectsABSTRACT
There are two main types of layer V pyramidal neurons in rat cortex. Type I neurons have tufted apical dendrites extending into layer I, produce bursts of action potentials and project to subcortical targets (spinal cord, superior colliculus and pontine nuclei). Type II neurons have apical dendrites, which arborize in layers II-IV, do not produce bursts of action potentials and project to ipsilateral and contralateral cortex. The specific expression of different genes and proteins in these two distinct layer V neurons is unknown. To distinguish between distinct subpopulations, fluorescent microspheres were injected into subcortical targets (labeling type I neurons) or primary somatosensory cortex (labeling type II neurons) of adult rats. After transport, cortical sections were processed for immunohistochemistry using various antibodies. This study demonstrated that antigens recognized by SMI-32, N200 and FNP-7 antibodies were only expressed in subcortical (type I)--but not in contralateral (type II)--projecting neurons. NR1, NR2a/b, PLCbeta1, BDNF, NGF and TrkB antigens were highly expressed in all neuronal subpopulations examined. Organotypic culture experiments demonstrated that the development of neurofilament expression and laminar specificity does not depend on the presence of the subcortical targets. This study suggests specific markers for the subcortical projecting layer V neuron subpopulations.
Subject(s)
Neurofilament Proteins/biosynthesis , Pyramidal Cells/metabolism , Animals , Gene Expression Regulation/physiology , Neurofilament Proteins/analysis , Pyramidal Cells/chemistry , Pyramidal Cells/cytology , Rats , Rats, WistarABSTRACT
Neuronal survival in the vertebrate peripheral nervous system depends on neurotrophic factors available from target tissues. In an attempt to identify novel survival factors, we have studied the effect of secreted factors from retinal cells on the survival of chick sympathetic ganglion neurons. Embryonic day 10 sympathetic neurons undergo programmed cell death after 48 h without appropriate levels of nerve growth factor (NGF). Retina Conditioned Media (RCM) from explants of embryonic day 11 retinas maintained for 4 days in vitro supported 90% of E10 chick sympathetic neurons after 48 h. Conditioned medium from purified chick retinal Muller glial cells supported nearly 100% of E10 chick sympathetic neurons. Anti-NGF (1 microg/mL) blocked the survival effect of NGF, but did not block the trophic effect of RCM. Neither BDNF nor NT4 (0.1-50 ng/mL) supported E10 sympathetic neuron survival. Incubation of chimeric immunoglobulin-receptors TrkA, TrkB, or TrkC had no effect on RCM-induced sympathetic neuron survival. The survival effects were not blocked by anti-GDNF, anti-TGFbeta, and anti-CNTF and were not mimicked by FGFb (0.1-10 nM). LY294002 at 50 microM, but not PD098059 blocked sympathetic survival induced by RCM. Further, the combination of RCM and NGF did not result in an increase in neuronal survival compared with NGF alone (82% survival after 48 h). The secreted factor in RCM is retained in subfractions with a molecular weight above 100 kDa, binds to heparin, and is unaffected by dialysis, but is heat sensitive. Our results indicate the presence of a high-molecular weight retinal secreted factor that supports sympathetic neurons in culture.